Does RESMETIROM Cause Off label use? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Off label use have been filed in association with RESMETIROM (REZDIFFRA). This represents 0.6% of all adverse event reports for RESMETIROM.
5
Reports of Off label use with RESMETIROM
0.6%
of all RESMETIROM reports
1
Deaths
2
Hospitalizations
How Dangerous Is Off label use From RESMETIROM?
Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RESMETIROM. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RESMETIROM Cause?
Diarrhoea (182)
Nausea (162)
Pruritus (147)
Alanine aminotransferase increased (98)
Aspartate aminotransferase increased (97)
Fatigue (72)
Abdominal pain upper (69)
Dizziness (68)
Vomiting (60)
Weight decreased (47)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RESMETIROM Alternatives Have Lower Off label use Risk?
RESMETIROM vs RESTASIS
RESMETIROM vs RETINOL
RESMETIROM vs REVATIO
RESMETIROM vs REVEFENACIN
RESMETIROM vs REVLIMID